Jamborova Gabriela, Pospisilova Nada, Semecky Vladimir, Hyspler Radomir, Ticha Alena, Pospechova Katerina, Solichova Dagmar, Maxová Martina, Briestensky Jiri, Real Keith J, Nachtigal Petr
Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
Nutrition. 2008 Nov-Dec;24(11-12):1174-81. doi: 10.1016/j.nut.2008.05.021. Epub 2008 Jul 21.
The aim of this study was to determine whether Microdispersed Oxidized Cellulose (MDOC) possesses a hypolipidemic effect in apolipoprotein-E/low-density lipoprotein receptor double-knockout (ApoE/LDLR-deficient) mice and the possible mechanism of this effect in mice.
Female ApoE/LDLR-deficient mice subdivided into two groups were fed with a Western-type diet for 8 wk, and the experimental group was supplemented with 5% MDOC for 8 wk. Female C57BL/6J mice were fed an atherogenic diet containing 5% MDOC or pectin for the determination of a possible hypolipidemic mechanism of MDOC action.
Biochemical analysis showed that 5% MDOC treatment significantly decreased total cholesterol by 20% (P = 0.0338) and very-LDL cholesterol by 21% (P = 0.0110) and significantly increased the level of high-density lipoprotein cholesterol by 62% (P = 0.0172) when compared with non-treated ApoE/LDLR-deficient mice. The results Association of Official Analytical Chemists method 991.43 revealed that MDOC contains 59.78 +/- 5.0% of fiber. Furthermore, it was demonstrated that administration of MDOC did not affect cholesterol absorption in the small intestine. Using C57BL/6J mice, MDOC and pectin treatments decreased cholesterol content in liver and increased fermentation in the gut in vivo. In vitro experiments confirmed that MDOC is fermentable under conditions mimicking those in the large intestine.
We demonstrated hypolipidemic effects of MDOC in ApoE/LDLR-deficient mice. Moreover, we propose that MDOC is a hypolipidemic soluble fiber acting probably by increased fermentation and production of short-chain fatty acids in the large intestine in mice. We propose that MDOC might be a possible source of soluble fiber for use in dietary supplements.
本研究旨在确定微分散氧化纤维素(MDOC)对载脂蛋白E/低密度脂蛋白受体双敲除(ApoE/LDLR缺陷)小鼠是否具有降血脂作用及其在小鼠体内产生这种作用的可能机制。
将雌性ApoE/LDLR缺陷小鼠分为两组,给予西式饮食8周,实验组补充5% MDOC 8周。给雌性C57BL/6J小鼠喂食含5% MDOC或果胶的致动脉粥样硬化饮食,以确定MDOC作用的可能降血脂机制。
生化分析表明,与未处理的ApoE/LDLR缺陷小鼠相比,5% MDOC处理使总胆固醇显著降低20%(P = 0.0338),极低密度脂蛋白胆固醇降低21%(P = 0.0110),高密度脂蛋白胆固醇水平显著升高62%(P = 0.0172)。美国官方分析化学家协会方法991.43的结果显示,MDOC含有59.78±5.0%的纤维。此外,已证明给予MDOC不影响小肠中的胆固醇吸收。使用C57BL/6J小鼠,MDOC和果胶处理降低了肝脏中的胆固醇含量,并在体内增加了肠道发酵。体外实验证实,MDOC在模拟大肠条件下是可发酵的。
我们证明了MDOC对ApoE/LDLR缺陷小鼠具有降血脂作用。此外,我们提出MDOC是一种降血脂的可溶性纤维,可能通过增加小鼠大肠中短链脂肪酸的发酵和产生而起作用。我们提出MDOC可能是用于膳食补充剂的可溶性纤维的一个可能来源。